{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:14:21Z","timestamp":1788786861705,"version":"build-2803163510"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>Acquired amegakaryocytic thrombocytopenic purpura (AATP) is a rare bone marrow disorder characterized by either a marked decrease or a complete absence of megakaryocytes with the preservation of all other cell lines. To date, more than 60 cases of AATP have been reported in the literature. Due to the rarity of this disease, no standard treatment guidelines have been established, and therapy is based on a handful of case studies and expert opinions. Herein, we provide a comprehensive review of currently utilized therapeutic options for AATP.<\/jats:p>","DOI":"10.56875\/2589-0646.1063","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T04:11:21Z","timestamp":1680581481000},"page":"279-290","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Acquired Amegakaryocytic Thrombocytopenic Purpura: A Review of Therapeutic Options"],"prefix":"10.4103","volume":"16","author":[{"given":"Syed A.","family":"Hussain","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneeqa","family":"Zafar","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, University of California San Francisco, 500 Parnassus Avenue, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa","family":"Faisal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Ud Din","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"R7-20241211","first-page":"124","article-title":"Study on the pathogenesis of acquired pure amegakaryocytic thrombocytopenic purpura","volume":"20","author":"Lu","year":"1999","journal-title":"Zhong- hua Xue Ye Xue Za Zhi"},{"key":"R12-20241211","first-page":"806","article-title":"Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE)","volume":"8","author":"Cela","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"key":"R13-20241211","first-page":"96","article-title":"Amegakar- yocytic thrombocytopenic purpura","volume":"38","author":"Harjai","year":"1992","journal-title":"J Postgrad Med"},{"key":"R40-20241211","first-page":"41","article-title":"Anti- CD20 Antibody is effective in the patient with refractory amegakaryocytic thrombocytopenia, 25 Months Follow up","volume":"8","author":"Mirzania","year":"2014","journal-title":"Int J Hematol Oncol Stem Cell Res"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.56875\/2589-0646.1063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:41:04Z","timestamp":1787838064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.56875\/2589-0646.1063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.56875\/2589-0646.1063","relation":{},"ISSN":["1658-3876","2589-0646"],"issn-type":[{"value":"1658-3876","type":"print"},{"value":"2589-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"assertion":[{"value":"2021-11-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}